Esma Andaç Uzdogan

Dr. Esma Andaç Uzdogan

orcid

Research Focus & Metrics

Academic Career Length

7Years (2020-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
2 August 2021 in Gynecological Endocrinology
Verified
Journal Article
Closed access
EUEsma Andaç Uzdogan
Esma Andaç Uzdogan
MPMeryem Pekcan
Meryem Pekcan
ACAylin Pelin Cil
Aylin Pelin Cil
UKUcler Kisa
Ucler Kisa
FAFiliz Akbiyik
Filiz Akbiyik
In this study, levels of progranulin (PGRN) and tumor necrosis factor-alpha (TNF-α) were measured to detect the presence of inflammation in lean polycystic ovary (PCOS) patients. 40 lean PCOS patients were assessed by Rotterdam criteria. Forty healthy women with regular menstrual cycles and without biochemical and clinical hyperandrogenism were involved in our study. Blood samples were taken from the patient and control groups for the measurement of progranulin (PGRN), tumor necrosis factor-alpha (TNF-α), lipid parameters, glucose, insulin, and other hormones. Serum PGRN and TNF-α levels were significantly higher in patients with lean PCOS, compared with the control group (p = .037, p = .041). PGRN levels were positively correlated with TNF-α levels in lean PCOS patients. PGRN is known as a ligand for the TNF-α receptor. PGRN level increase in lean PCOS patients may be due to inhibiting the inflammatory effects of TNF-α. To observe the PGRN and TNF-α connection in obesity, further study is needed in obese PCOS patients and obese control groups.

26 April 2023 in Laboratory Medicine
Verified
Journal Article
Open access
PDF file
MKMehmet Kayaalp
Mehmet Kayaalp
AEAbdulsamet Erden
Abdulsamet Erden
HAHakan Apaydin
Hakan Apaydin
SGSerdar Can Güven
Serdar Can Güven
BABerkan Armağan
Berkan Armağan
OKOrhan Kucuksahin
Orhan Kucuksahin
Semaphorin 3A (Sema3A) plays a regulatory role in immune responses. The aim of this study was to evaluate Sema3A levels in patients with systemic sclerosis (SSc), especially in major vascular involvements such as digital ulcer (DU), scleroderma renal crisis (SRC), pulmonary arterial hypertension (PAH), and to compare Sema3A level with SSc disease activity. In SSc patients, patients with DU, SRC, or PAH were grouped as major vascular involvements and those without as nonvascular, and Sema3A levels were compared between the groups and with a healthy control group. The Sema3A levels and acute phase reactants in SSc patients, as well as their association with the Valentini disease activity index and modified Rodnan skin score, were evaluated. The Sema3A values (mean ± SD) were 57.60 ± 19.81 ng/mL in the control group (n = 31), 44.32 ± 5.87 ng/mL in patients with major vascular involvement SSc (n = 21), and 49.96 ± 14.00 ng/mL in the nonvascular SSc group (n = 35). When all SSc patients were examined as a single group, the mean Sema3A value was significantly lower than controls (P = .016). The SSc with major vascular involvement group had significantly lower Sema3A levels than SSc with nonmajor vascular involvement group (P = .04). No correlation was found between Sema3A, acute phase reactants, and disease activity scores. Also, no relationship was observed between Sema3A levels and diffuse (48.36 ± 11.47 ng/mL) or limited (47.43 ± 12.38 ng/mL) SSc types (P = .775). Our study suggests that Sema3A may play a significant role in the pathogenesis of vasculopathy and can be used as a biomarker in SSc patients with vascular complications such as DU and PAH.

20 December 2025 in Journal of Affective Disorders
Verified
Journal Article
Closed access
YAYağmur Darben Azarsız
Yağmur Darben Azarsız
AKAybeniz Civan Kahve
Aybeniz Civan Kahve
EÜEzgi Sıla Ahi Üstün
Ezgi Sıla Ahi Üstün
EUEsma Andaç Uzdogan
Esma Andaç Uzdogan
NNNagihan Ayaz Naycı
Nagihan Ayaz Naycı
HKHasan Kaya
Hasan Kaya

29 October 2020 in Turkish Journal of Biochemistry
Verified
Journal Article
Open access
GYGülsen Yılmaz
Gülsen Yılmaz
NANurullah Aydoğan
Nurullah Aydoğan
SSSevilay Sezer
Sevilay Sezer
STSezen Tutar
Sezen Tutar
EUEsma Andaç Uzdogan
Esma Andaç Uzdogan
FYFatma Meriç Yılmaz
Fatma Meriç Yılmaz
Objectives: The aim of this study is to identify the possible effects of the Ministry of Health regulation on Vitamin D testing and vitamin D deficiency detection and to investigate the effect of the reflex test algorithm implementation. Materials and methods: A total of requested 78,919 25(OH)D and 5,653 1,25(OH)2D test results were examined. Test requests were classified in 3 groups according to the Regulation; Group 1: Requests from inpatients and intensive care units, Group 2: Requests from outpatients of non-restricted departments, Group 3: Requests from outpatients of restricted departments. In addition, the reflex test algorithm was simulated and the name of the 1,25-dihydroxyvitamin D test request was changed to 1,25-dihydroxycholecalciferol. Results: Changing the test name as 1,25 dihydroxycholecalciferol reduced the number of monthly test requests (−71.7%). The hypovitaminous detection rate was similar in Group 1, 2, and 3 in the 25(OH)D requests and was higher in the reflex test algorithm. In 1,25(OH)2D requests, the rate of hypovitaminous detection was higher in Group 1 than in Group 2 and 3. Discussion: With simple acts like using structured test ordering forms, reflex test algorithms applied in the clinic-laboratory-interface involving Medical Biochemistry Specialists, bigger impact with less underdiagnosis might be possible in test demand management.

19 August 2025 in Calcified Tissue International
Verified
Journal Article
Closed access
PDF file
GBGonul Buyukyilmaz
Gonul Buyukyilmaz
SKSerkan Bilge Koca
Serkan Bilge Koca
RGRefika Gören
Refika Gören
EUEsma Andaç Uzdogan
Esma Andaç Uzdogan
KAKeziban Toksoy Adıguzel
Keziban Toksoy Adıguzel
FGFatih Gürbüz
Fatih Gürbüz

1 November 2021 in Turkish Journal of Biochemistry
Verified
Journal Article
Open access
PDF file
EOEsra Fırat Oguz
Esra Fırat Oguz
MFMesude Falay
Mesude Falay
MKMüjgan Ercan Karadağ
Müjgan Ercan Karadağ
EUEsma Andaç Uzdogan
Esma Andaç Uzdogan
EAEmiş Deniz Akbulut
Emiş Deniz Akbulut
TTTuran Turhan
Turan Turhan
Objectives: Recent advances in hematology analyzers have enabled to improve the reliability in the results and also provided additional hematological parameters. In the present study, we aimed to determine the reference ranges for automated erythrocyte and reticulocyte parameters in healthy individuals on Sysmex XN 1000 hematology analyzer. Methods: One hundred and thirty-three subjects with normal physical examination and complete blood count results within the reference ranges were included in the study. Venous blood samples collected in tubes containing K 2 -EDTA were analyzed on Sysmex XN-1000. The references intervals for IRF, RBC He, Ret He, LFR, MFR, HFR, Delta He, Micro R, Macro R, Hypo He and Hyper He were determined according to CLSI EP28-A3c. Results: The reference ranges of the parameters were estimated with 90% confidence intervals. The reference ranges were 3.4–17% for IRF, 26.9–32.8 pg for Ret-He, 25.2–30.5 pg for RBC-He and 0.5–3.7 pg for delta-He. Gender specific reference ranges were calculated for of Ret-He (male (M): 26.8–32.9 pg, female (F): 23.9–33.6 pg), RBC-He (M: 26.3–30.8 pg, F: 25.3–30.5 pg) and delta-He (M: 0.5–3.7 pg, F: 0.3–3.7 pg). Conclusions: The new reticulocyte and erythrocyte parameters may be conveniently used in clinical diagnosis and follow-up of patients, as they offer reliable, automated and cheap results. Each laboratory is recommended to determine its own reference intervals considering the differences like the instrument used and population studied.